CD4 and neoplasm: It is clear that CD4+ T cells are critical effectors in anti-tumour immunity as highlighted by a recent paper by Brentville et al., demonstrating the critical role of CD4+ T cells in mediating anti-cancer response to peptide vaccines [141].